透口甲状腺切除术与开放甲状腺切除术对格雷夫斯病的外科结果的比较
Suo-Hsien Wang1, Wu-Po Chao1, Ta-You Lo2
1Department of General Surgery, Chang Gung Memorial Hospital, Keelung, Taiwan.
Surgical laparoscopy, endoscopy & percutaneous techniques
|February 15, 2024
概括
透口内镜甲状腺切除术前庭治疗方法 (TOETVA) 是一个安全的,无痕的选择,用于Graves病患者. 这项研究发现,在结果和并发症方面,TOETVA与开放性甲状腺切除术相当.
科学领域:
- 内分泌学 在内分泌学.
- 手术瘤学手术瘤学
- 最少侵入性的手术
背景情况:
- 透口内镜甲状腺切除术前庭治疗方法 (TOETVA) 提供无痕甲状腺切除术用于.
- 关于TOETVA对Graves病的数据有限.
- 这项研究将TOETVA与Graves病患者的开放甲状腺切除术 (OT) 进行比较.
研究的目的:
- 为了比较TOETVA与OT在患有Graves病的患者的全甲状腺切除术中的安全性和有效性.
- 评估两种方法之间的手术结果和并发症率.
主要方法:
- 在2017年9月至2022年10月期间接受双边全甲状腺切除术的格雷夫斯病患者的回顾性研究.
- 在TOETVA和OT组之间比较患者人口统计学,手术时间,血液流失,停留时间和并发症.
- 每组有15名患者.
主要成果:
- 托特瓦患者的年龄明显较小 (35.8岁与51.5岁).
- 手术时间,血液流失,术后停留,并发症率 (甲状腺下垂症,神经损伤,感染,出血,复发) 在两组之间相似.
- 完全的甲状腺切除术在两组的甲状腺蛋白水平中得到证实;没有发生TOETVA到开放转换.
结论:
- 在经过精心挑选的格雷夫斯病患者中,TOETVA是开放甲状腺切除术的安全,可行的,无痕的替代方案.
- 这种方法提供了与传统开放手术相比较的外科结果和并发症概况.
相关概念视频
01:23The Thyroid Gland
7.1K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
7.1K
01:27Hyperthyroidism II: Pathophysiology
58
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
58
01:28Graves' Disease I: Introduction
52
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
52
01:24Graves Disease II: Pathophysiology
59
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
59